𝛼SK or Search

ENTITY

Repligen Corp (RGEN US)

16

Analysis

Health Care • United States

Repligen Corporation is a bioprocessing company focused on the development, production, and commercialization of innovative products used in the process of manufacturing biologic drugs. The Company's customers include life sciences companies, global biopharmaceutical companies, and contract manufacturers worldwide.

more

Refresh

Exchange Announcement • 06 Oct 2026 21:14

Current Report (Form 8-K | Period ending 2026-10-06)

Exchange Announcement • 30 Sep 2026 18:01

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 09 Sep 2026 05:27

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 09 Sep 2026 05:26

Current Report (Form 8-K | Period ending 2026-09-03)

Exchange Announcement • 05 Sep 2026 05:19

424B3 | Prospectus

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x